Middle Eastern Penny Stocks With Market Caps Under US$400M

In This Article:

As Gulf bourses display mixed results, with investors on the lookout for new catalysts amid fluctuating oil prices and shifting global trade dynamics, attention turns to the potential of smaller market players. Penny stocks, a term that may seem outdated, still hold relevance as they often represent smaller or newer companies with significant growth potential. This article will explore three such stocks from the Middle East that combine financial strength with promising opportunities for investors seeking hidden value.

Top 10 Penny Stocks In The Middle East

Name

Share Price

Market Cap

Financial Health Rating

Thob Al Aseel (SASE:4012)

SAR4.17

SAR1.67B

★★★★★★

Keir International (SASE:9542)

SAR3.95

SAR474M

★★★★★☆

Alarum Technologies (TASE:ALAR)

₪2.797

₪195.88M

★★★★★★

Terminal X Online (TASE:TRX)

₪4.535

₪575.97M

★★★★★★

Oil Refineries (TASE:ORL)

₪0.927

₪2.88B

★★★★★☆

Tgi Infrastructures (TASE:TGI)

₪2.207

₪164.07M

★★★★★★

Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)

AED0.701

AED426.39M

★★★★★★

Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR)

AED2.88

AED332.64M

★★★★★★

E7 Group PJSC (ADX:E7)

AED1.00

AED2.02B

★★★★★★

Dubai Investments PJSC (DFM:DIC)

AED2.38

AED10.03B

★★★★☆☆

Click here to see the full list of 93 stocks from our Middle Eastern Penny Stocks screener.

Let's explore several standout options from the results in the screener.

Gulf Pharmaceutical Industries P.S.C

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Gulf Pharmaceutical Industries P.S.C., along with its subsidiaries, operates in the manufacturing and sale of medicines, drugs, and various pharmaceutical, cosmetic, and medical compounds across the United Arab Emirates, other GCC countries, and internationally with a market cap of AED1.59 billion.

Operations: The company's revenue is primarily derived from its Manufacturing segment, which generated AED864.9 million, and its Planet segment, contributing AED732.9 million.

Market Cap: AED1.59B

Gulf Pharmaceutical Industries P.S.C. has demonstrated significant financial improvement, becoming profitable over the past year with a net income of AED 140.9 million in Q1 2025, up from AED 1.9 million the previous year. The company maintains strong short-term asset coverage over both its short and long-term liabilities, and its debt is well managed with a satisfactory net debt to equity ratio of 4.8%. Despite low return on equity at 2.4%, earnings quality remains high, supported by stable weekly volatility and reduced debt levels from previous years, reflecting prudent financial management amidst growing revenues forecasted at 6.91% annually.